Home Orion Corporation

Orion Corporation

In operation
IPO
Developer of Veterinary Drugs and Active Pharmaceutical Ingredients
Basic
Enterprise Profile

Basic Information

Orion Corporation develops, manufactures, and sells human and veterinary drugs as well as active pharmaceutical ingredients. The company continuously develops new drugs and treatment methods. The core therapeutic areas of Orion's drug research and development are neurological disorders, oncology, and respiratory diseases, for which Orion has developed inhaled pulmonary medications. Orion's customers are primarily healthcare service providers and professionals, such as specialists and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories.
Orion Corporation
Finland
more than 500 people
January 01, 1970
firstname.lastname@orion.fi

Enterprise Profile

Industrial Sector
New Drug Development Drug Trial Veterinary Drug Manufacturing and Production
Concept
Tumor # Nervous System Diseases Respiratory Diseases Therapeutic Products Prostate Cancer
Application Scenarios
Innovative Drugs Veterinary Drugs